CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, Dec. 28, 2025 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology and oncology, today announced that it has entered...
Hence then, the article about harbour biomed enters into long term strategic collaboration with lannacheng to advance next generation radionuclide drug conjugates was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Harbour BioMed Enters into Long-Term Strategic Collaboration with Lannacheng to Advance Next-Generation Radionuclide Drug Conjugates )
Also on site :
- 1982 Steven Spielberg Tearjerker, Featuring One of the Saddest Movie Scenes Ever, Is Still Just as Powerful 44 Years Later
- 1976 Rock Song, Written by Tom Petty After His Solo Deal Fell Apart, Launched One of Rock’s Greatest Bands
- 1989 Phil Collins Single, the 'Worst Song Ever About Homelessness,' Became the Last No. 1 Hit of the '80s